These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
68 related items for PubMed ID: 7682096
1. Mitogenic and dedifferentiating effect of the K-fgf/hst oncogene on rat thyroid PC clone 3 epithelial cells. Battaglia C, Berlingieri MT, Martelli ML, Trapasso F, Delli Bovi P, Fusco A. Cell Growth Differ; 1993 Mar; 4(3):185-92. PubMed ID: 7682096 [Abstract] [Full Text] [Related]
2. The v-erbA oncogene selectively inhibits iodide uptake in rat thyroid cells. Trapasso F, Martelli ML, Battaglia C, Angotti E, Mele E, Stella A, Samarut J, Avvedimento VE, Fusco A. Oncogene; 1996 May 02; 12(9):1879-88. PubMed ID: 8649848 [Abstract] [Full Text] [Related]
3. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype. Coppa A, Mincione G, Lazzereschi D, Ranieri A, Turco A, Lucignano B, Scarpa S, Ragano-Caracciolo M, Colletta G. J Cell Physiol; 1997 Aug 02; 172(2):200-8. PubMed ID: 9258341 [Abstract] [Full Text] [Related]
4. TPA induces a block of differentiation and increases the susceptibility to neoplastic transformation of a rat thyroid epithelial cell line. Portella G, Vitagliano D, Li Z, Sferratore F, Santoro M, Vecchio G, Fusco A. Oncol Res; 1998 Aug 02; 10(9):441-7. PubMed ID: 10223619 [Abstract] [Full Text] [Related]
5. Human N-ras, TRK-T1, and RET/PTC3 oncogenes, driven by a thyroglobulin promoter, differently affect the expression of differentiation markers and the proliferation of thyroid epithelial cells. Portella G, Vitagliano D, Borselli C, Melillo RM, Salvatore D, Rothstein JL, Vecchio G, Fusco A, Santoro M. Oncol Res; 1999 Aug 02; 11(9):421-7. PubMed ID: 10821536 [Abstract] [Full Text] [Related]
6. Endogenous fibroblast growth factor-1 or fibroblast growth factor-2 modulate prostate cancer cell proliferation. Shain SA, Sarić T, Ke LD, Nannen D, Yoas S. Cell Growth Differ; 1996 May 02; 7(5):573-86. PubMed ID: 8732667 [Abstract] [Full Text] [Related]
7. Transformation by basic fibroblast growth factor requires high levels of expression: comparison with transformation by hst/K-fgf. Quarto N, Talarico D, Sommer A, Florkiewicz R, Basilico C, Rifkin DB. Oncogene Res; 1989 May 02; 5(2):101-10. PubMed ID: 2608276 [Abstract] [Full Text] [Related]
8. Dual effect of transforming growth factor beta on rat thyroid cells: inhibition of thyrotropin-induced proliferation and reduction of thyroid-specific differentiation markers. Colletta G, Cirafici AM, Di Carlo A. Cancer Res; 1989 Jul 01; 49(13):3457-62. PubMed ID: 2543498 [Abstract] [Full Text] [Related]
9. Angiogenic activity of the K-fgf/hst oncogene in neural transplants. Brüstle O, Aguzzi A, Talarico D, Basilico C, Kleihues P, Wiestler OD. Oncogene; 1992 Jun 01; 7(6):1177-83. PubMed ID: 1375717 [Abstract] [Full Text] [Related]
10. Expression of the K-fgf protooncogene is repressed during differentiation of F9 cells. Velcich A, Delli-Bovi P, Mansukhani A, Ziff EB, Basilico C. Oncogene Res; 1989 Jun 01; 5(1):31-7. PubMed ID: 2780052 [Abstract] [Full Text] [Related]
11. Expression of fibroblast growth factor-5 by bovine choroidal endothelial cells in vitro. Keithahn MA, Aotaki-Keen AE, Schneeberger SA, Hjelmeland LM, Morse LS. Invest Ophthalmol Vis Sci; 1997 Sep 01; 38(10):2073-80. PubMed ID: 9331271 [Abstract] [Full Text] [Related]
12. Multiple aspects of the phenotype of mammary epithelial cells transformed by expression of activated M-Ras depend on an autocrine mechanism mediated by hepatocyte growth factor/scatter factor. Zhang KX, Ward KR, Schrader JW. Mol Cancer Res; 2004 Apr 01; 2(4):242-55. PubMed ID: 15140946 [Abstract] [Full Text] [Related]
13. HST-1/FGF-4 plays a critical role in crypt cell survival and facilitates epithelial cell restitution and proliferation. Sasaki H, Hirai K, Yamamoto H, Tanooka H, Sakamoto H, Iwamoto T, Takahashi T, Terada M, Ochiya T. Oncogene; 2004 Apr 29; 23(20):3681-8. PubMed ID: 15116099 [Abstract] [Full Text] [Related]
17. Fibroblast growth factor-2 over-rides insulin-like growth factor-I induced proliferation and cell survival in human neuroblastoma cells. Russo VC, Andaloro E, Fornaro SA, Najdovska S, Newgreen DF, Bach LA, Werther GA. J Cell Physiol; 2004 Jun 29; 199(3):371-80. PubMed ID: 15095284 [Abstract] [Full Text] [Related]
18. Exogenous fibroblast growth factors maintain viability, promote proliferation, and suppress GADD45alpha and GAS6 transcript content of prostate cancer cells genetically modified to lack endogenous FGF-2. Shain SA. Mol Cancer Res; 2004 Nov 29; 2(11):653-61. PubMed ID: 15561781 [Abstract] [Full Text] [Related]
19. Differential growth factor production, secretion, and response by high and low metastatic variants of B16BL6 melanoma. Blanckaert VD, Schelling ME, Elstad CA, Meadows GG. Cancer Res; 1993 Sep 01; 53(17):4075-81. PubMed ID: 8358737 [Abstract] [Full Text] [Related]
20. Intracellular FGF-2 promotes differentiation in T-47D breast cancer cells. Korah RM, Sysounthone V, Scheff E, Wieder R. Biochem Biophys Res Commun; 2000 Oct 14; 277(1):255-60. PubMed ID: 11027671 [Abstract] [Full Text] [Related] Page: [Next] [New Search]